We demonstrated that in animal models, cytotoxic analogs of LH-RH, somatostatin and bombesin may each have very powerful inhibitory effects on cancers that express the corresponding receptors for the carrier peptide; these hybrid compounds are more effective and less toxic than the cytotoxic radicals alone. Here, GNRH1 is linked to cancer.